ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Zota Health Care (ZOTA.NSE)
Zota Health Care share price today, ATLAS forecast and fair value
Healthcare · Biotechnology · National Stock Exchange of India · India
₹1,195▼ -3.82%
Prices as of Oct 26, 2026 · INR
Chance of rising in 1 month
49%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Zota Health Care in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Zota Health Care
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Zota Health Care a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹1,093 and ₹1,296; in 9 out of 10, between ₹939.87 and ₹1,507. Estimated annual volatility is 51%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₹47.1B
- Market cap (USD)
- $497M
- Dividend yield
- 0.29%
- 52-week high
- ₹1,740
- 52-week low
- ₹1,022
- Revenue (12 months)
- ₹6.1B
- Operating margin
- -22.7%
- Net margin
- -17.0%
- Beta
- 0.37
What this means
ATLAS does not publish a fair value for ZOTA.NSE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks ZOTA.NSE has traded between ₹1,022 and ₹1,740. Today it is 31.3% below that high and 17% above its low.
Its beta is 0.37: it tends to move less than the market.
About the company
Zota Health Care Limited is a prominent pharmaceutical company engaged in the manufacturing and marketing of a wide range of healthcare products.
Want to see everything about Zota Health Care?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Zota Health Care do?
Zota Health Care Limited is a prominent pharmaceutical company engaged in the manufacturing and marketing of a wide range of healthcare products.
What is the chance ZOTA.NSE goes up next month?
49%: close to a coin flip. In half of the simulated outcomes, ZOTA.NSE ends the month between ₹1,093 and ₹1,296.
How big is Zota Health Care and what is its P/E ratio?
Zota Health Care's market capitalization is ₹47.1B. We do not show a P/E because it has no positive earnings to base one on.
Does Zota Health Care pay a dividend?
Yes. ZOTA.NSE's current dividend yield is 0.29% at today's price (₹1,195).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer